BSE Live
Nov 07, 12:13Prev. Close
2003.65
Open Price
2005.00
Bid Price (Qty.)
1925.50 (1)
Offer Price (Qty.)
1927.35 (4)
NSE Live
Nov 07, 12:13Prev. Close
2004.40
Open Price
2003.00
Bid Price (Qty.)
1925.60 (2)
Offer Price (Qty.)
1926.00 (55)
| Balance Sheet of Caplin Point Laboratories (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 9 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 15.13 | 15.13 | 15.12 | 15.12 | 15.11 | |
| Total Share Capital | 15.13 | 15.13 | 15.12 | 15.12 | 15.11 | |
| Reserves and Surplus | 575.34 | 410.06 | 277.19 | 184.91 | 109.29 | |
| Total Reserves and Surplus | 575.34 | 410.06 | 277.19 | 184.91 | 113.03 | |
| Total Shareholders Funds | 599.91 | 432.05 | 295.60 | 200.12 | 128.14 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 0.02 | 0.29 | 0.32 | 0.48 | 0.73 | |
| Deferred Tax Liabilities [Net] | 22.14 | 22.54 | 22.16 | 18.97 | 11.33 | |
| Other Long Term Liabilities | 5.01 | 1.94 | 5.38 | 0.05 | 0.00 | |
| Long Term Provisions | 0.00 | 0.00 | 0.00 | 0.40 | 1.63 | |
| Total Non-Current Liabilities | 27.16 | 24.77 | 27.86 | 19.90 | 13.69 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 0.27 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade Payables | 51.41 | 59.50 | 72.90 | 66.01 | 53.01 | |
| Other Current Liabilities | 11.71 | 21.76 | 13.86 | 29.37 | 60.37 | |
| Short Term Provisions | 0.87 | 1.25 | 0.58 | 1.67 | 7.39 | |
| Total Current Liabilities | 64.26 | 82.51 | 87.34 | 97.05 | 120.77 | |
| Total Capital And Liabilities | 691.33 | 539.33 | 410.80 | 317.07 | 262.60 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 163.53 | 136.17 | 167.40 | 150.45 | 142.15 | |
| Intangible Assets | 3.39 | 1.59 | 1.92 | 1.30 | 0.60 | |
| Capital Work-In-Progress | 3.77 | 8.62 | 15.29 | 3.42 | 0.23 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 170.70 | 146.39 | 184.61 | 155.17 | 142.98 | |
| Non-Current Investments | 135.54 | 98.62 | 1.87 | 14.58 | 1.43 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 2.21 | 4.43 | 9.08 | 10.59 | 3.37 | |
| Other Non-Current Assets | 2.15 | 1.94 | 2.03 | 0.00 | 0.00 | |
| Total Non-Current Assets | 310.59 | 251.37 | 197.59 | 180.34 | 147.78 | |
| CURRENT ASSETS | ||||||
| Current Investments | 60.23 | 69.62 | 46.34 | 4.20 | 0.00 | |
| Inventories | 22.37 | 23.52 | 28.46 | 22.29 | 17.90 | |
| Trade Receivables | 218.98 | 125.39 | 86.35 | 3.21 | 6.80 | |
| Cash And Cash Equivalents | 58.27 | 44.85 | 28.28 | 76.66 | 64.77 | |
| Short Term Loans And Advances | 20.45 | 24.01 | 23.47 | 27.74 | 22.88 | |
| OtherCurrentAssets | 0.43 | 0.56 | 0.31 | 2.63 | 2.47 | |
| Total Current Assets | 380.74 | 287.95 | 213.21 | 136.73 | 114.82 | |
| Total Assets | 691.33 | 539.33 | 410.80 | 317.07 | 262.60 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 26.56 | 74.63 | 74.22 | 0.00 | 7.62 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 68.67 | 76.82 | 53.63 | 67.73 | 59.12 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 9.73 | 13.13 | 10.45 | 10.85 | 0.57 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 2.34 | 6.43 | 5.86 | 7.52 | 1.46 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | 0.08 | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | 494.13 | 521.15 | 409.90 | 325.61 | 215.81 | |
| Other Earnings | -- | -- | -- | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | 0.04 | 0.04 | 12.95 | -- | |
| Non-Current Investments Unquoted Book Value | -- | 0.29 | 0.30 | 1.63 | 1.39 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | 60.56 | 69.62 | 46.34 | -- | -- | |
| Current Investments Unquoted Book Value | 5.42 | -- | -- | 4.20 | -- |
05.11.2025
Caplin Labs Consolidated September 2025 Net Sales at Rs 534.04 crore, up 10.54% Y-o-Y
28.08.2025
21.08.2025
07.08.2025
Caplin Labs Standalone June 2025 Net Sales at Rs 182.57 crore, down 1.65% Y-o-Y
05.11.2025
Caplin Labs Consolidated September 2025 Net Sales at Rs 534.04 crore, up 10.54% Y-o-Y
07.08.2025
Caplin Labs Standalone June 2025 Net Sales at Rs 182.57 crore, down 1.65% Y-o-Y
15.05.2025
Caplin Labs Consolidated March 2025 Net Sales at Rs 502.45 crore, up 10.86% Y-o-Y
15.05.2025
Caplin Labs Standalone March 2025 Net Sales at Rs 173.61 crore, up 24.56% Y-o-Y